#

Dailypharm Live Search Close
  • Contaminated COVID vaccines, national petition for special investigation
  • by Lee, Jeong-Hwan | translator Hong, Ji Yeon | 2026-03-10 08:55:51
Petitioner says "Special investigation needed to investigate appropriateness of administrative response"
People Power Party raises accountability issues against Minister Jeong Eun Kyeong (Former Commissioner)
People Power Party says "Minister Jeong must resign"
정은경 복지부
Minister of Health and Welfare Jeong Eun Kyeong

Following confirmation by disease control authorities of negligence in the management of foreign substances in COVID-19 vaccines, a national petition has been filed requesting the appointment of a Special Prosecutor to investigate the allegations.

With multiple opposition lawmakers raising accountability issues against Minister of Health and Welfare Jeong Eun Kyeong, attention has been drawn to the progress of the petition.

On the 6th, a petition was field on the National Assembly's e-People service stating, "We request the introduction of a Special Prosecuter to clearly investigate the foreign substance issues reported during the COVID-19 vaccine management process and the appropriateness of the administrative response."

The petitioner demanded a Special Prosecutor investigation into the entire process of reporting and responding to foreign substances in COVID-19 vaccines. The request includes verifying the legality of reporting, recall, and quality control procedures; determining accountability; and conducting a full-scale investigation into potential external pressure or conflict-of-interest involvement.

Furthermore, the petitioner urged the National Assembly to disclose the full results of the investigation, improve systems to prevent recurrence, and restore the public's right to know and trust in public health.

According to the 'Diagnostics and Analysis of COVID-19 Response Status' report released by the Board of Audit and Inspection of Korea (BAI) on the 23rd of last month, the Korea Disease Control and Prevention Agency (KDCA) failed to notify the Ministry of Food and Drug Safety (MFDS) of foreign substance reports. Instead, they handled the issue by informing only the manufacturers and did not suspend vaccination with the same batch numbers despite the risk.

Specifically, between March 2021 and October 2024, the KDCA received 1,285 reports of foreign substances in COVID-19 vaccines from medical institutions but bypassed the MFDS, opting to receive investigation results directly from manufacturers.

While the majority of these cases (835, 65%) involved rubber stopper fragments due to usage errors, 127 cases (9.9%) involved hazardous foreign substances, including mold, hair, and silicon dioxide.

Notably, because no suspension of administration was ordered for the vaccines containing hazardous substances, approximately 14.2 million doses from those specific batch numbers continued to be administered even after the reports were made.

Based on the BAI announcement, the petitioner argued, "There is a need for an independent verification of potential deficiencies in the management and reporting systems, and whether the actions of the KDCA and MFDS complied with relevant laws and manuals," adding, "An objective investigation is also required regarding whether external pressure or conflict-on-interest interests influenced policy decisions during the reporting and management process."

The petitioner further asserted, "It must be clarified whether the administrative agency's judgments were made based on public health principles or influenced by specific organizations or companies. Given that this matter directly affects national health, it is difficult to restore trust solely through internal executive branch investigations. The facts and accountability must be clarified through an investigation independent of political interests."

Separate from the national petition, the opposition party is holding the Minister of Health and Welfare accountable for the contaminated COVID-19 vaccines.

The People Power Party (PPP), citing the BAI report that contaminated vaccines were administered due to management failure during the pandemic, requested that Rep. Choo Mi-ae (Democratic Party), Chairperson of the Legislation and Judiciary Committee, cooperate in holding an emergency inquiry.

Shin Dong-wook, Senior Supreme Council Member of the PPP, pointed out during a Supreme Council meeting on the 5th, "We requested the Democratic Party to hold an emergency inquiry into the BAI at the Legislation and Judiciary Committee, but Chairperson Choo is refusing, stating without reason that the committee cannot be convened."

Rep. Na Kyung-won, the designated opposition lead for the Legislation and Judiciary Committee, also posted on Facebook yesterday, "According to KDCA data, there were 485,576 reports of adverse reactions, 2,802 deaths, and 1,285 reports of foreign substances. However, vaccinations were not stopped." Rep. Na added, "I will demand an emergency meeting of the Legislation and Judiciary Committee, the immediate withdrawal of government appeals [in vaccine lawsuits], the resignation of former Commissioner Jeong, and a parliamentary investigation."

Rep. Kim Mi-ae, the PPP executive secretary of the Health and Welfare Committee, also stated at a PP meeting, "The status of COVID-19 vaccine management is a total failure that seriously threatens national health. It is a clinical experiment conducted by the state on innocent citizens." Rep. Kim urged Minister Jeong, who was the KDCA Commissioner at the time, to "take immediate responsibility, resign, and fully cooperate with the investigation."

  • 0
Reader Comment
0
Member comment Write Operate Rule
Colse

댓글 운영방식은

댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.

댓글 노출방식은

댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.

댓글의 삭제 기준은

다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.

  • 저작권·인격권 등 타인의 권리를 침해하는 경우

    상용 프로그램의 등록과 게재, 배포를 안내하는 게시물

    타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물

  • 근거 없는 비방·명예를 훼손하는 게시물

    특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우

    특정 지역 및 종교간의 감정대립을 조장하는 내용

    사실 확인이 안된 소문을 유포 시키는 경우

    욕설과 비어, 속어를 담은 내용

    정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)

    특정 지역이나 단체를 비하하는 경우

    특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우

    특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우

    타인의 ID 혹은 닉네임을 도용하는 경우

  • 게시판 특성상 제한되는 내용

    서비스 주제와 맞지 않는 내용의 글을 게재한 경우

    동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우

    부분적으로 변경하여 반복 게재하는 경우도 포함

    제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우

    돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물

    게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우

  • 수사기관 등의 공식적인 요청이 있는 경우

  • 기타사항

    각 서비스의 필요성에 따라 미리 공지한 경우

    기타 법률에 저촉되는 정보 게재를 목적으로 할 경우

    기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용

  • 사실 관계 확인 후 삭제

    저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우

    타인의 초상권을 침해하거나 개인정보를 유출하는 경우

    당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)

  • ※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.

    ※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.

    ※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.

If you want to see the full article, please JOIN US (click)